Azathramycin (CAS No 76801-85-9) is a macrolide antibiotic primarily used in biomedical research focused on its antimicrobial properties Originating from the Streptomyces species its mechanism of action involves inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit This action effectively halts bacterial growth exhibiting common in vitro activity in the nanomolar to low micromolar range Researchers use Azathramycin predominantly in cell models and animal studies to explore its efficacy and safety profile It is frequently employed in drug screening processes to identify potential therapeutic applications Experimental concentrations typically depend on the specific research design allowing for flexibility in different study contexts The compound plays a significant role in studies aiming to understand and combat bacterial infections contributing to advancements in antibiotic therapy development